SREBF1 and metabolic dysfunction-associated steatotic liver disease: Adiponectin is said to have a protective effect in NAFLD by potentiating insulin’s ability to decrease glucose production and output, as well as down-regulating SREBP-1c and suppressing lipogenesis.